Published by
Reuters
Reuters
By Ankur Banerjee and Michael Erman (Reuters) – A U.S. decision on Pfizer and BioNTech’s COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data. The FDA had planned to make a decision on the vaccine based on early trial data because of what it had called a great public health need due to the surge in infections caused by the Omicron variant of the coronavirus. The decision was slated for next week with a rollout starting as soon as Feb. 21. On Friday, the agency said it had reviewe…
